Status:
COMPLETED
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Dry Eye Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the safety and efficacy of an ophthalmic solution in dry eye disease.
Eligibility Criteria
Inclusion
- Subjects 18 years of age or older
Exclusion
- No active ocular conditions of disease
Key Trial Info
Start Date :
August 13 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2009
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00758784
Start Date
August 13 2008
End Date
January 14 2009
Last Update
September 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISTA Pharmaceuticals, Inc.
Irvine, California, United States, 92618